Oncology & Cancer

New plan of attack in cancer fight

New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern medicine: a cure for cancer.

Medications

FDA: Akynzeo approved for chemo-related nausea / vomiting

(HealthDay)—The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among people undergoing chemotherapy, the agency said Friday ...

Medical research

Clinical trials pave way to new cystic fibrosis drug

Imagine breathing through only a tiny straw. That is what life is like for people with cystic fibrosis, which includes about 30,000 people in the United States, making cystic fibrosis the most common lethal genetic disease ...

Oncology & Cancer

Targeting bladder cancer's Achilles heel: stem cells

Two different proteins work separately as well as synergistically to feed a small pool of stem cells that help bladder cancer resist chemotherapy, research led by a Johns Hopkins Kimmel Cancer Center scientist suggests. The ...

Obstetrics & gynaecology

Drug combination promotes weight loss in polycystic ovary syndrome

Women with polycystic ovary syndrome, or PCOS, lost significantly more weight when they took two drugs that are traditionally used to treat diabetes, rather than either drug alone, a study from Slovenia demonstrates. The ...

Diseases, Conditions, Syndromes

Drug combination defeats dengue, Ebola in mice, study finds

A combination of two cancer drugs inhibited both dengue and Ebola virus infections in mice in a study led by Stanford University School of Medicine researchers, despite the fact that these two viruses are vastly different ...

page 15 from 33